<DOC>
	<DOCNO>NCT01416376</DOCNO>
	<brief_summary>SRT2379 potent small molecule activator SIRT1 find inhibit systemic inflammation induce intravenous injection lipopolysaccharide ( LPS ) mouse . The objective study determine effect single administration SRT2379 , multiple-dose level , inflammatory response low dose endotoxin .</brief_summary>
	<brief_title>Effect Multiple Dose Levels SRT2379 Endotoxin-Induced Inflammation</brief_title>
	<detailed_description />
	<criteria>Healthy , determine responsible experienced physician , base medical evaluation include medical history , physical examination ( PE ) laboratory test carry within 21 day prior Day 1 . A subject clinical abnormality laboratory parameter outside reference range population study may include Investigator Medical Monitor agree find unlikely introduce additional risk factor interfere study procedure Male 18 35 year age , inclusive , time signing informed consent Capable give write informed consent able comply requirement restriction list informed consent form Chemistry panel , include renal liver function test , without clinically relevant abnormality judge Investigator Subjects must agree use doublebarrier birth control abstinence participate study 7 day follow last dose study drug Subject major illness past 3 month significant chronic medical illness Investigator would deem unfavourable enrolment , include inflammatory disease Subjects history type malignancy exception successfully treat basal cell cancer skin Subject past current gastrointestinal disease may influence drug absorption The subject know positive test hepatitis C antibody , hepatitis B surface antigen human immunodeficiency virus ( HIV ) antibody 1 2 Current chronic history liver disease , know hepatic biliary abnormality ( exception Gilbert 's syndrome asymptomatic gallstone ) Subject history , within 3 year , drug abuse ( include benzodiazepine , opioids , amphetamine , cocaine , THC , methamphetamine ) positive drug result Screening visit History alcoholism and/or drink 3 unit alcohol per day . Alcoholism define average weekly intake &gt; 21 unit male . One unit equivalent 8 g alcohol : halfpint ( ~240 mL ) beer , 1 glass ( 125 mL ) wine 1 ( 25 mL ) measure spirit The subject receive investigational product within three month first dose day current study ; Note : subject participate prior human endotoxemia study SRT2379 SRT2104 would exclude participation trial . Use prescription nonprescription drug herbal dietary supplement within 7 day unless opinion Investigator medication interfere study procedure compromise subject safety Subject difficulty donate blood limited accessibility vein leave right arm Subject donate 350 mL blood last 3 month Subject us tobacco product Any clinically relevant abnormality note 12lead ECG judge Investigator average QTcB QTcF &gt; 450 msec Any issue , opinion Investigator , could harmful subject compromise interpretation data Prior participation trial subject receive intravenous endotoxin ( LPS ) infusion</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>